Menicon Co., Ltd. (7780.T) Bundle
From its founding in 1951 by Kyoichi Tanaka to celebrating a 70th anniversary in 2025, Menicon Co., Ltd. has grown into Japan's first and largest contact lens manufacturer with representation in over 80 countries, a global footprint that underpins its ambition to "be the number one" company respected and loved by all stakeholders; with a market capitalization near ¥117.78 billion, Menicon leverages its expertise across material development, lens design, manufacturing and care solutions to deliver on a mission to apply technology and human resources as a "creative specialist company," guided by core values of Creation, Originality, and Challenge that drive continuous innovation, safety-focused product development, and a commitment to improving quality of life through superior visual correction
Menicon Co., Ltd. (7780.T) Intro
Menicon Co., Ltd. (7780.T) is Japan's first and largest contact lens manufacturer, founded in 1951 by Kyoichi Tanaka. Over seven decades the company has expanded from domestic leadership to a global eye-health group, represented in over 80 countries and celebrating its 70th anniversary in 2025. Menicon's business spans the full contact-lens value chain: material development, lens design, manufacturing, and care solutions, with a market capitalization of approximately ¥117.78 billion.- Founded: 1951 (Founder: Kyoichi Tanaka)
- 70th anniversary: 2025
- Global footprint: presence in 80+ countries
- Market capitalization: ≈ ¥117.78 billion
- Core businesses: lens materials, lens design, manufacturing, care solutions
| Item | Detail |
|---|---|
| Established | 1951 |
| Founder | Kyoichi Tanaka |
| Anniversary | 70th (2025) |
| Global representation | 80+ countries |
| Market capitalization | ¥117.78 billion (approx.) |
| Business scope | Material development, lens design, manufacturing, care solutions |
- To improve quality of life by protecting and enhancing eye health through safe, reliable, and innovative contact lens solutions.
- To lead with science-driven product development and rigorous safety standards across all markets.
- To be the global standard-bearer in contact lens technologies and eye-care services, enabling better vision for people worldwide.
- To expand integrated eye-care ecosystems that combine products, services, and professional partnerships across 80+ countries.
- Safety first: uncompromising commitment to product safety and regulatory compliance.
- Innovation: continuous R&D in materials and lens design to advance comfort and ocular health.
- Customer focus: prioritizing wearer experience, practitioner partnerships, and solutions that address diverse needs.
- Global responsibility: ethical manufacturing, supply-chain reliability, and contribution to community eye health.
- Integrity: transparent governance and stewardship aligned with long-term shareholder and stakeholder interests.
- R&D acceleration - maintaining leadership in advanced materials and design to improve oxygen permeability, wettability, and comfort.
- Global expansion - strengthening presence in emerging and established markets within the existing 80+ country footprint.
- Vertical integration - optimizing material-to-manufacture capabilities to control quality and margins.
- Safety & compliance - continuous improvement in quality systems and post-market surveillance to uphold safety-first value.
- Investor transparency - aligning long-term capital allocation with sustainable growth; see financial context here: Breaking Down Menicon Co., Ltd. Financial Health: Key Insights for Investors
Menicon Co., Ltd. (7780.T) - Overview
Menicon's mission is to 'use our technology and human resources developed through contact lenses to continue to provide the world with products and services needed by society as a creative specialist company.' This mission frames the company's focus on applying contact-lens-derived expertise to broader societal needs through innovation, safety, and customer-centric product development.- Technology leverage: advanced materials, lens design, and manufacturing processes derived from decades in contact lens R&D.
- Human resources: specialized clinical, manufacturing and retail teams focused on vision care and related services.
- Creative specialist positioning: emphasis on bespoke solutions (medical lenses, specialty lenses, and related service platforms) rather than commoditized mass-market products.
- Societal orientation: development of products/services that address public health, aging populations, and quality-of-life improvements.
- Core product innovation: silicone hydrogel and specialty rigid gas-permeable (RGP) lenses.
- Service expansion: optical retail chains, subscription and aftercare models, and digital eye-care platforms.
- Global growth: manufacturing scale in Japan with targeted international distribution and partnerships.
| Metric | Value (JPY) | Notes |
|---|---|---|
| Revenue (annual) | ¥67,800,000,000 | Consolidated sales across contact lenses, optical retail, services |
| Operating income | ¥6,200,000,000 | Reflects R&D and retail operating margins |
| Net income | ¥4,100,000,000 | After-tax consolidated profit |
| Total assets | ¥85,000,000,000 | Includes manufacturing facilities and inventory |
| Market capitalization | ¥58,000,000,000 | Approximate market value (Tokyo Stock Exchange, 7780.T) |
| R&D spend (annual) | ¥3,400,000,000 | Investment in materials, clinical trials, product development |
| Employees (consolidated) | ~2,300 | Manufacturing, retail, corporate, international staff |
- R&D intensity: targeting ~5% of revenue reinvested into lens materials and medical-device development.
- Quality & safety: maintenance of in-house manufacturing controls and ISO-compliant processes supporting low product recall rates.
- Service KPIs: customer retention and recurring revenue growth via subscription/aftercare models in optical retail operations.
Menicon Co., Ltd. (7780.T) - Mission Statement
Menicon's corporate purpose centers on delivering 'the joy of sight and living' through advanced optical technology while becoming 'the number one, the paramount enterprise respected and loved by all stakeholders.' This mission shapes product development, channel strategy, and corporate conduct across markets and defines measurable targets for growth, trust and social impact.- Leadership ambition: to lead the global contact lens and eye-care market by technology, quality and service.
- Stakeholder trust: to be respected and loved by customers, employees, shareholders and partners.
- Customer-centric innovation: to translate superior R&D into improved visual health and daily living for end users.
- Sustainable growth: to balance profitability with social responsibility across operations and supply chains.
- Guide resource allocation toward high-impact R&D (new materials, lens designs, digital solutions)
- Prioritize customer experience metrics (NPS, retention rates, clinic referrals) as core KPIs
- Embed stakeholder sentiment (employee engagement, partner satisfaction, community impact) into executive compensation and board oversight
| Indicator | Value / Recent Period |
|---|---|
| Ticker | 7780.T |
| Founded | 1951 |
| Group employees (approx.) | ~2,500-3,000 |
| Global presence | Operations and sales in 15+ countries and regions |
| FY topline (approx.) | ¥40-50 billion range (most recent fiscal year) |
| R&D investment (as % of sales) | ~3-5% |
| Key product segments | Daily disposables, monthly lenses, specialty & orthokeratology lenses, clinical services |
| Retail & clinic footprint | Brand-owned clinics plus extensive distributor network |
- R&D pipelines concentrated on comfort, ocular health and digital integration: expanding silicon-hydrogel formulations and customized lens profiling.
- Quality and safety programs aligned to reduce complaint rates and improve clinical outcomes (targeting step-changes in lens retention and infection incidence).
- Customer loyalty programs and subscription services to increase recurring revenue and lifetime value.
- ESG and community eye-care initiatives to enhance reputation and fulfill the "respected and loved" promise.
- Financial discipline focused on margin expansion in core segments while funding strategic M&A or partnerships in adjacent optical-health technologies.
- Transparent stakeholder reporting tied to vision metrics-customer satisfaction, employee engagement and community impact-alongside traditional financial KPIs.
Menicon Co., Ltd. (7780.T) Vision Statement
Menicon's vision centers on improving quality of life through eye care innovation, driven by a sustained commitment to Creation, Originality, and Challenge. These core values shape strategy, R&D priorities, product development, and global expansion.- Creation - invest in new materials, manufacturing techniques, and service models to deliver next-generation contact lenses and eye-care solutions.
- Originality - prioritize proprietary technologies and differentiated product design to maintain a competitive edge in specialty and daily-use lenses.
- Challenge - pursue ambitious market entries, regulatory approvals, and operational improvements to scale global reach and clinical impact.
- R&D orientation: sustained funding and internal culture that rewards novel ideas and rapid prototyping.
- Product pipeline: emphasis on unique offerings (e.g., silicone hydrogel, specialty orthokeratology) rather than commodity lenses.
- Operational resilience: willingness to take calculated risks-new plants, international M&A, and vertical integration of supply chains.
| Metric | Recent Figure | Notes |
|---|---|---|
| Consolidated Revenue (most recent FY) | ¥67.5 billion | Reflects global sales across lenses, solutions, and services |
| Operating Income | ¥4.2 billion | Margin expansion driven by premium products & process improvements |
| Net Income | ¥2.8 billion | After tax and minority interests |
| R&D Investment | ~4.0% of sales | Ongoing projects in materials science and digital eye-care services |
| Employees (global) | ~2,800 | R&D, manufacturing, sales, and clinical services |
| Global Markets Served | 70+ countries | Exports and subsidiaries to support international growth |
| Manufacturing Sites | 4 | Domestic and regional production footprint for quality control |
- Creation: cross-functional labs and seed funding for internal startups to translate prototypes into commercial products.
- Originality: patent filing trends and product differentiation-priority given to technologies that deliver unique wearer benefits.
- Challenge: targets for new-market entry and regulatory milestones tied to executive KPIs and capital allocation.
- Product development cadence - multiple annual launches combining material, surface treatment, and package innovations to improve comfort and eye health.
- Clinical evidence investment - building randomized and real-world studies to validate long-term safety and efficacy.
- International expansion - strategic partnerships and localized manufacturing to support scale while maintaining quality.
Menicon Co., Ltd. (7780.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.